Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 7
Submit an article Journal homepage
337
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluations

Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

José Vicente Fernández-MonteroHospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain+34 91 4532500; +34 91 7336614; [email protected]
, MD, PhD for Drs,
Eugenia VispoHospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain+34 91 4532500; +34 91 7336614; [email protected]
, MD for Dr,
Lourdes AntaHospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain+34 91 4532500; +34 91 7336614; [email protected]
, PhD for Dr,
Carmen de MendozaHospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain+34 91 4532500; +34 91 7336614; [email protected]
, PhD for Dr &
Vincent SorianoHospital Carlos III, Department of Infectious Diseases, Calle Sinesio Delgado 10, 28029 Madrid, Spain+34 91 4532500; +34 91 7336614; [email protected]
, MD, PhD for Drs
Pages 1007-1014 | Published online: 20 Apr 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yali Wang, Erik De Clercq & Guangdi Li. (2019) Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 813-829.
Read now
Rana Zainuddin, Zahid Zaheer, Jaiprakash N. Sangshetti & Mufassir Momin. (2017) Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation. Drug Development and Industrial Pharmacy 43:12, pages 2076-2084.
Read now
Jose V Fernandez-Montero, Eugenia Eugenia, Pablo Barreiro, Pablo Labarga & Vicente Soriano. (2013) Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management. Expert Opinion on Drug Safety 12:5, pages 697-707.
Read now
José Vicente Fernández-Montero, Eugenia Vispo, Lourdes Anta, Carmen de Mendoza & Vincent Soriano. (2012) Author's response: expert reviews: who are they for?. Expert Opinion on Pharmacotherapy 13:8, pages 1217-1218.
Read now
Nathan Ford & Alexandra Calmy. (2012) Expert reviews: who are they for?. Expert Opinion on Pharmacotherapy 13:8, pages 1083-1085.
Read now

Articles from other publishers (9)

Priyanka Vallabh DeulkarMukthinuthalapati Mathrusri Annapurna. (2023) A New stability indicating RP-UFLC method for the estimation of Rilpivirine in pharmaceutical dosage forms. Research Journal of Pharmacy and Technology, pages 3456-3462.
Crossref
Saima Aftab, Sevinc Kurbanoglu, Goksu Ozcelikay, Nurgul K. Bakirhan, Afzal Shah & Sibel A. Ozkan. (2019) Carbon quantum dots co-catalyzed with multiwalled carbon nanotubes and silver nanoparticles modified nanosensor for the electrochemical assay of anti-HIV drug Rilpivirine. Sensors and Actuators B: Chemical 285, pages 571-583.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 687 736 .
Weisi Xu, Jianxiong Zhao, Jianping Sun, Qianqian Yin, Yan Wang, Yang Jiao, Junyi Liu, Shibo Jiang, Yiming Shao, Xiaowei Wang & Liying Ma. (2015) The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes. Antimicrobial Agents and Chemotherapy 59:8, pages 4882-4888.
Crossref
María José Abad Martínez, Luis Miguel Bedoya del Olmo & Paulina Bermejo Benito. 2014. 197 221 .
Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li & Charlotte I.S. Barker. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 401 443 .
Steffen Wildum, Daniela Paulsen, Kai Thede, Helga Ruebsamen-Schaeff & Holger Zimmermann. (2013) In Vitro and In Vivo Activities of AIC292, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor . Antimicrobial Agents and Chemotherapy 57:11, pages 5320-5329.
Crossref
Joaquín Portilla & Vicente Estrada. (2013) Mecanismo de acción y farmacocinética de rilpivirina. Enfermedades Infecciosas y Microbiología Clínica 31, pages 2-5.
Crossref
Lourdes Anta, Josep M. Llibre, Eva Poveda, José L. Blanco, Marta Álvarez, María J. Pérez-Elías, Antonio Aguilera, Estrella Caballero, Vicente Soriano & Carmen de Mendoza. (2013) Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies. AIDS 27:1, pages 81-85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.